Medical Condition Contrave is FDA-approved for weight management in people with a body mass index (BMI) of more than 30, or a BMI of more than 27 with another weight-related condition, like high blood pressure, Type 2 diabetes, or high cholesterol
Gallbladder-related events, including cholelithiasis and cholecystitis, occur more frequently with GLP-1 therapy, likely related to rapid weight loss rather than direct drug effects
Those with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should avoid these medications
According to the Anxiety and Depression Association of America, around half of adults with ADHD also have anxiety disorder
Food and Drug Administration approved the first gene therapy for young children with sickle cell disease
Anticarcinogenic action of quercetin by downregulation of phosphatidylinositol 3-kinase (PI3K) and protein kinase C (PKC) via induction of p53 in hepatocellular carcinoma (HepG2) cell line
